Your browser doesn't support javascript.
loading
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Wan, Marilyn T; Shin, Daniel B; Winthrop, Kevin L; Gelfand, Joel M.
Afiliação
  • Wan MT; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Shin DB; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Winthrop KL; Division of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon.
  • Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: joel.gelfand@pennme
J Am Acad Dermatol ; 83(2): 677-679, 2020 08.
Article em En | MEDLINE | ID: mdl-32416207
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Psoríase / Produtos Biológicos / Infecções por Coronavirus / Interleucina-17 / Tomada de Decisão Clínica / Betacoronavirus Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Psoríase / Produtos Biológicos / Infecções por Coronavirus / Interleucina-17 / Tomada de Decisão Clínica / Betacoronavirus Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2020 Tipo de documento: Article